Solta Medical releases new radiofrequency device
Aesthetic device manufacturer, Solta Medical Ltd, has released the Thermage FLX system, a radiofrequency device designed to tighten skin.
Aesthetic device manufacturer, Solta Medical Ltd, has released the Thermage FLX system, a radiofrequency device designed to tighten skin.
Hyaluronic acid dermal filler Restylane Kysse has been approved by the US Food and Drug Administration (FDA) for lip augmentation and the correction of upper perioral rhytids.
A survey has indicated that only 22.5% of practitioners follow the recommended protocol for treating headaches with botulinum toxin.
A study conducted by the Food and Drug Administration (FDA) has revealed that many common sunscreen ingredients can result in exposure levels which exceed the FDA threshold for safety testing.
Light emitting diode (LED) device manufacturer Celluma has added two new products to its portfolio; the DELUX and DELUX XL.
The Food and Drug Administration (FDA) has approved AKLIEF (trifarotene) Cream 0.005% for the topical treatment of acne.
On March 19 the Food and Drug Administration (FDA) issued letters of warning to two US breast implant manufacturers, Mentor Worldwide LLC and Sientra Inc.
The Food and Drug Administration (FDA) has approved Jeuveau, a botulinum toxin type A, for the temporary improvement in the appearance of moderate to severe glabellar lines.